Universal Biosensors, Inc. (UBI.AX)
AUD 0.06
(-1.54%)
AUD 0.06
(-1.54%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 3.22 Million AUD | -19.34% |
| 2022 | 3.99 Million AUD | 136.54% |
| 2021 | 1.69 Million AUD | -53.49% |
| 2020 | 3.63 Million AUD | 11105.1% |
| 2019 | 32.44 Thousand AUD | 0.0% |
| 2018 | - AUD | -100.0% |
| 2017 | 19.02 Million AUD | -6.2% |
| 2016 | 20.28 Million AUD | 2.11% |
| 2015 | 19.86 Million AUD | 13.54% |
| 2014 | 17.49 Million AUD | 10.35% |
| 2013 | 15.85 Million AUD | 0.0% |
| 2012 | - AUD | 0.0% |
| 2011 | - AUD | 0.0% |
| 2010 | - AUD | 0.0% |
| 2009 | - AUD | 0.0% |
| 2008 | - AUD | 0.0% |
| 2007 | - AUD | 0.0% |
| 2006 | - AUD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q3 | - AUD | 0.0% |
| 2024 Q1 | 3.06 Million AUD | 0.0% |
| 2024 Q2 | 2.78 Million AUD | 0.0% |
| 2023 Q1 | 3.83 Million AUD | -4.1% |
| 2023 Q4 | 3.22 Million AUD | -8.59% |
| 2023 FY | 3.22 Million AUD | -19.34% |
| 2023 Q2 | 3.71 Million AUD | -3.05% |
| 2023 Q3 | 3.52 Million AUD | -5.09% |
| 2022 Q2 | 4.54 Million AUD | 1.01% |
| 2022 FY | 3.99 Million AUD | 136.54% |
| 2022 Q1 | 4.49 Million AUD | 166.02% |
| 2022 Q3 | 4.34 Million AUD | -4.44% |
| 2022 Q4 | 3.99 Million AUD | -7.88% |
| 2021 FY | 1.69 Million AUD | -53.49% |
| 2021 Q4 | 1.69 Million AUD | -10.16% |
| 2021 Q1 | 2.12 Million AUD | -41.56% |
| 2021 Q2 | 2 Million AUD | -5.65% |
| 2021 Q3 | 1.88 Million AUD | -6.11% |
| 2020 Q4 | 3.63 Million AUD | -3.52% |
| 2020 Q1 | 4.02 Million AUD | 12301.7% |
| 2020 Q2 | 3.9 Million AUD | -2.98% |
| 2020 FY | 3.63 Million AUD | 11105.1% |
| 2020 Q3 | 3.76 Million AUD | -3.48% |
| 2019 Q3 | - AUD | 0.0% |
| 2019 FY | 32.44 Thousand AUD | 0.0% |
| 2019 Q2 | - AUD | 0.0% |
| 2019 Q1 | - AUD | 0.0% |
| 2019 Q4 | 32.44 Thousand AUD | 0.0% |
| 2018 Q4 | - AUD | 0.0% |
| 2018 Q1 | 19.39 Million AUD | 1.94% |
| 2018 FY | - AUD | -100.0% |
| 2018 Q2 | - AUD | -100.0% |
| 2018 Q3 | - AUD | 0.0% |
| 2017 Q2 | 19.18 Million AUD | -0.35% |
| 2017 Q3 | 18.88 Million AUD | -1.6% |
| 2017 Q4 | 19.02 Million AUD | 0.78% |
| 2017 FY | 19.02 Million AUD | -6.2% |
| 2017 Q1 | 19.25 Million AUD | -5.08% |
| 2016 Q1 | 19.01 Million AUD | -4.32% |
| 2016 FY | 20.28 Million AUD | 2.11% |
| 2016 Q4 | 20.28 Million AUD | 5.74% |
| 2016 Q3 | 19.18 Million AUD | -2.4% |
| 2016 Q2 | 19.65 Million AUD | 3.4% |
| 2015 Q2 | 18.79 Million AUD | -0.32% |
| 2015 Q3 | 20.64 Million AUD | 9.87% |
| 2015 Q1 | 18.85 Million AUD | 7.74% |
| 2015 Q4 | 19.86 Million AUD | -3.78% |
| 2015 FY | 19.86 Million AUD | 13.54% |
| 2014 FY | 17.49 Million AUD | 10.35% |
| 2014 Q3 | 16.35 Million AUD | 7.94% |
| 2014 Q1 | 15.43 Million AUD | -2.69% |
| 2014 Q4 | 17.49 Million AUD | 7.01% |
| 2014 Q2 | 15.14 Million AUD | -1.83% |
| 2013 Q4 | 15.85 Million AUD | 0.0% |
| 2013 Q2 | - AUD | 0.0% |
| 2013 Q1 | - AUD | 0.0% |
| 2013 FY | 15.85 Million AUD | 0.0% |
| 2013 Q3 | - AUD | 0.0% |
| 2012 Q4 | - AUD | 0.0% |
| 2012 Q3 | - AUD | 0.0% |
| 2012 Q2 | - AUD | 0.0% |
| 2012 FY | - AUD | 0.0% |
| 2011 Q3 | - AUD | 0.0% |
| 2011 Q2 | - AUD | 0.0% |
| 2011 Q4 | - AUD | 0.0% |
| 2011 FY | - AUD | 0.0% |
| 2010 Q4 | - AUD | 0.0% |
| 2010 Q3 | - AUD | 0.0% |
| 2010 FY | - AUD | 0.0% |
| 2010 Q2 | - AUD | 0.0% |
| 2009 Q2 | - AUD | 0.0% |
| 2009 FY | - AUD | 0.0% |
| 2009 Q4 | - AUD | 0.0% |
| 2008 FY | - AUD | 0.0% |
| 2008 Q4 | - AUD | 0.0% |
| 2008 Q2 | - AUD | 0.0% |
| 2007 Q2 | - AUD | 0.0% |
| 2007 FY | - AUD | 0.0% |
| 2007 Q4 | - AUD | 0.0% |
| 2006 FY | - AUD | 0.0% |
| 2006 Q4 | - AUD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| 4DMedical Limited | 4.17 Million AUD | 22.757% |
| Adherium Limited | - AUD | -Infinity% |
| Aroa Biosurgery Limited | 5.89 Million AUD | 45.322% |
| Atomo Diagnostics Limited | - AUD | -Infinity% |
| Anteris Technologies Ltd | 1.52 Million AUD | -110.936% |
| Control Bionics Limited | 336.16 Thousand AUD | -859.556% |
| CardieX Limited | - AUD | -Infinity% |
| Compumedics Limited | - AUD | -Infinity% |
| Cochlear Limited | 202.1 Million AUD | 98.404% |
| CleanSpace Holdings Limited | 2.76 Million AUD | -16.598% |
| Cyclopharm Limited | 4.01 Million AUD | 19.616% |
| EMVision Medical Devices Ltd | 1.76 Million AUD | -82.61% |
| Nova Eye Medical Limited | - AUD | -Infinity% |
| HeraMED Limited | - AUD | -Infinity% |
| Imricor Medical Systems, Inc. | 12.43 Million AUD | 74.064% |
| ImpediMed Limited | 810 Thousand AUD | -298.233% |
| InhaleRx Limited | - AUD | -Infinity% |
| LBT Innovations Limited | 1.74 Million AUD | -85.065% |
| Micro-X Limited | 65 Thousand AUD | -4862.602% |
| Neurotech International Limited | - AUD | -Infinity% |
| OncoSil Medical Limited | - AUD | -Infinity% |
| PolyNovo Limited | 742 Thousand AUD | -334.729% |
| Respiri Limited | - AUD | -Infinity% |
| SomnoMed Limited | 709.07 Thousand AUD | -354.916% |
| Uscom Limited | - AUD | -Infinity% |
| Visioneering Technologies, Inc. | - AUD | -Infinity% |